[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ZA885069B - Sustained-release percutaneous preparations - Google Patents

Sustained-release percutaneous preparations

Info

Publication number
ZA885069B
ZA885069B ZA885069A ZA885069A ZA885069B ZA 885069 B ZA885069 B ZA 885069B ZA 885069 A ZA885069 A ZA 885069A ZA 885069 A ZA885069 A ZA 885069A ZA 885069 B ZA885069 B ZA 885069B
Authority
ZA
South Africa
Prior art keywords
sustained
application
release percutaneous
percutaneous preparations
skin
Prior art date
Application number
ZA885069A
Other languages
English (en)
Inventor
Yoshio Ueda
Ueda Yoshio
Sotoo Asakura
Asakura Sotoo
Yoshio Murakami
Murakami Yoshio
Toshiomi Nakate
Nakate Toshiomi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of ZA885069B publication Critical patent/ZA885069B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Nanotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA885069A 1987-07-24 1988-07-13 Sustained-release percutaneous preparations ZA885069B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18579087 1987-07-24

Publications (1)

Publication Number Publication Date
ZA885069B true ZA885069B (en) 1989-03-29

Family

ID=16176941

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA885069A ZA885069B (en) 1987-07-24 1988-07-13 Sustained-release percutaneous preparations

Country Status (9)

Country Link
US (1) US4889721A (de)
EP (1) EP0301424B1 (de)
JP (1) JP2638956B2 (de)
KR (1) KR890001525A (de)
AT (1) ATE88906T1 (de)
AU (1) AU606973B2 (de)
DE (1) DE3880754T2 (de)
ES (1) ES2054744T3 (de)
ZA (1) ZA885069B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5825490A (en) * 1989-06-02 1991-01-08 Charles Dewey Ebert Apparatus and methods for noninvasive blood glucose monitoring
US5139023A (en) * 1989-06-02 1992-08-18 Theratech Inc. Apparatus and method for noninvasive blood glucose monitoring
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
ES2196208T3 (es) * 1996-03-09 2003-12-16 Nitto Denko Corp Preparacion percutanea adhesiva.
US5948433A (en) * 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
GB0309631D0 (en) * 2003-04-28 2003-06-04 Bayer Cropscience Ag Novel process for the preparation of 2-aminomethylpyridine derivatives
US20050202073A1 (en) 2004-03-09 2005-09-15 Mylan Technologies, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
US9205062B2 (en) 2004-03-09 2015-12-08 Mylan Pharmaceuticals, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
JP4557596B2 (ja) * 2004-04-28 2010-10-06 積水化成品工業株式会社 外用貼付剤およびその製造方法、並びにその使用方法
WO2006091795A2 (en) * 2005-02-25 2006-08-31 Board Of Regents, The University Of Texas System METHODS AND COMPOSITIONS INVOLVING EXPRESSION OF α1C SUBUNIT OF L-TYPE CALCIUM CHANNELS IN SMOOTH MUSCLE CELLS
WO2007099966A1 (ja) * 2006-02-28 2007-09-07 Hisamitsu Pharmaceutical Co., Inc. 経皮吸収型製剤
KR101239150B1 (ko) * 2012-02-28 2013-03-06 에스케이케미칼주식회사 도네페질-함유 경피흡수제제 및 그의 제조방법
AR101476A1 (es) 2014-08-07 2016-12-21 Acerta Pharma Bv Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
JPS5530216B2 (de) * 1974-02-08 1980-08-09
JPS57120518A (en) * 1981-01-19 1982-07-27 Tanabe Seiyaku Co Ltd Preparation of microcapsule
JPS57130914A (en) * 1981-02-04 1982-08-13 Agency Of Ind Science & Technol Prolongation of activity retention
JPS5910513A (ja) * 1982-07-12 1984-01-20 Nitto Electric Ind Co Ltd 医薬製剤
JPS5920374A (ja) * 1982-07-24 1984-02-02 Dia Seiyaku Kk 貼付剤
DK311683A (da) * 1982-07-26 1984-01-27 Fujisawa Pharmaceutical Co Fremgangsmaade til fremstilling af pyridylalkylnitratforbindelser
JPS6081166A (ja) * 1983-10-11 1985-05-09 Fujisawa Pharmaceut Co Ltd ２−ニトロオキシメチル−６−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法
JPS60156607A (ja) * 1984-01-25 1985-08-16 Fujisawa Pharmaceut Co Ltd ２−ニトロオキシメチル−６−クロロピリジンまたはそのβ−シクロデキストリン包接化合物含有経皮吸収製剤
JPS6130517A (ja) * 1984-07-20 1986-02-12 Nichiban Co Ltd 三層構造より成る粘膜用貼付剤
JPS6215A (ja) * 1985-02-26 1987-01-06 Fujisawa Pharmaceut Co Ltd ２−ニトロオキシメチル−６−クロロピリジンまたはそのβ−シクロデキストリン包接化合物含有持続性製剤
EP0241806A1 (de) * 1986-04-14 1987-10-21 Fujisawa Pharmaceutical Co., Ltd. Transdermale Zubereitungen mit verzögerter Freisetzung
JP2969313B2 (ja) * 1992-10-15 1999-11-02 富士写真フイルム株式会社 放射線画像読取処理条件決定方法

Also Published As

Publication number Publication date
AU1970888A (en) 1989-01-27
ES2054744T3 (es) 1994-08-16
KR890001525A (ko) 1989-03-27
DE3880754T2 (de) 1993-10-07
JP2638956B2 (ja) 1997-08-06
EP0301424A2 (de) 1989-02-01
JPH01104008A (ja) 1989-04-21
US4889721A (en) 1989-12-26
ATE88906T1 (de) 1993-05-15
EP0301424A3 (en) 1989-07-12
AU606973B2 (en) 1991-02-21
DE3880754D1 (de) 1993-06-09
EP0301424B1 (de) 1993-05-05

Similar Documents

Publication Publication Date Title
ZA885069B (en) Sustained-release percutaneous preparations
IT1179635B (it) Composizione e preparato per la somministrazione di medicamenti per via cutanea
GR3006518T3 (de)
IT1130709B (it) Regolatore impiantabile per l'infusione di sostanze medicinali
AU609390B2 (en) Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs
DE3682457D1 (de) Geraet zur verabreichung von medikamenten an patienten.
AU591774B2 (en) Lysine salt of the gadolinium-dota complex and its applications to diagnosis
NO165803C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tertiaere hydroksyalkylxantiner.
JPS54122250A (en) Phenoxyalkylcarboxylic acid derivative*its manufacture and medicine containing said derivative and having blood platelet agglutination preventing activity and*or lipid reducing activity
AU2800689A (en) Differential delivery of therapeutic agents across the blood brain barrier
AU3683484A (en) The use of menthol to enhance transdermal drug delivery
PT83556B (de) Biologisch aktive derivate des human-gama-interferons ihre herstellung und arzneimittel die solche derivate enthalten
IT8521322A0 (it) Composti e composizioni farmaceutiche per la terapia di retinopatie e neuropatie diabetiche.
ES2090915T3 (es) Composiciones nutritivas o medicamentosas para la administracion a los rumiantes a base de citosano.
NO862321D0 (no) Fysiologisk middel for oekning av transdermal avlevering av legemidler.
EP0263174A4 (de) Erhöhte gefässperfusion nach verabreichung von lipiden.
EP0052085A3 (de) Pharmazeutische Zusammensetzung, die Vincamin enthält
IL85651A (en) Preparation of optically active oxo-isoindolinyl derivatives,some such novel dextrorotary isomers and pharmaceutical compositions containing the novel compounds
NL185666C (nl) Farmaceutisch preparaat of voorwerp en geneeskrachtige verbindingen.
EP0496474A3 (en) Saline derivates of glyceryl phosphoryl myoinositol having therapeutical activity, their preparation and pharmaceutical compositions containing them
IL83606A0 (en) Derivatives of 2,2-dimethyl-cyclopropanecarboxylic acid,their preparation and their use as insecticides and acaricides
DE3877499D1 (de) 2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.
AR242178A1 (es) Benzoilureas, excepto cuando son aplicadas en el hombre y animales superiores, preparacion y composiciones acaricidas e insecticidas que las contienen
RO89129A2 (ro) Produs medicamentos pentru tratamentul diareei la animale
ZA895124B (en) Pharmaceutical products containing the silver salt of sulfadiazine for topical external therapy